Coherus Oncology (CHRS.US) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Event Tracking

Nov14

H.C. Wainwright analyst reiterates buy rating on Coherus Biosciences

23:42

Nov7

Coherus Oncology released FY2025 Q3 earnings on November 6 After-Market EST, actual revenue USD 11.57 M (forecast USD 13 M), actual EPS USD -0.3056 (forecast USD -0.3564)

00:00

Coherus Oncology released FY2025 9 Months Earnings on November 6 After-Market EST, actual revenue USD 29.42 M, actual EPS USD 1.7712

00:00

Oct30

Coherus Oncology to Release FY2025 Q3 Earnings on November 6 After-Market (EST), Forecast Revenue USD 13.41 M, EPS USD -0.3539

00:09

Aug8

Intas Pharmaceuticals Acquires Coherus BioSciences' UDENYCA®

03:40

Aug7

Coherus Oncology released FY2025 Q2 earnings on August 7 After-Market (EST), actual revenue USD 10.25 M (forecast USD 9.28 M), actual EPS USD 2.5652 (forecast USD 0.6396)

23:00